Literature DB >> 25445560

Breast cancer. Risedronate reduces bone loss.

Robert Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25445560     DOI： 10.1038/nrclinonc.2014.214

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.

Authors:  Ivana Sestak; Shalini Singh; Jack Cuzick; Glen M Blake; Rajesh Patel; Fatma Gossiel; Rob Coleman; Mitch Dowsett; John F Forbes; Anthony Howell; Richard Eastell
Journal:  Lancet Oncol       Date:  2014-11-11       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.